论文部分内容阅读
[目的]观察通腑化浊方联合西药治疗早期缺血性脑中风疗效。[方法]使用随机平行对照方法,将96例住院患者按抽签法简单随机分为两组。对照组48例保持呼吸道通畅,预防吸入性肺炎,抗凝剂,早期溶栓,抗血小板聚集。治疗组48例通腑化浊方(生大黄6~10g,菖蒲20g,郁金15g,胆南星制、丹参各15g,地龙15g,桃仁、天麻各12g,黄芪、瓜萎各30g,全蝎粉冲服1g,水蛭粉冲服1g,三七粉冲服3g),1剂/d,水煎200m L,早晚口服;西药治疗同对照组。连续治疗4d为1疗程。观测临床症状、FMI评分、NIHSS评分、Ashworth评分、不良反应。连续治疗6疗程,判定疗效。[结果]治疗组痊愈12例,显效23例,有效13例,无效2例,总有效率95.83%。对照组痊愈2例,显效4例,有效10例,无效32例,总有效率33.33%。治疗组疗效优于对照组(P<0.01)。指标评分两组均有改善(P<0.01),治疗组改善优于对照组(P<0.05,P<0.01)。[结论]通腑化浊方联合西药治疗早期缺血性脑中风疗效满意,无严重不良反应,值得推广。
[Objective] To observe the curative effect of Tongfu Huazhun combined with western medicine on early ischemic stroke. [Methods] Randomized parallel control method was used to divide 96 inpatients randomly into two groups according to the random selection method. The control group, 48 cases of airway patency, prevention of aspiration pneumonia, anticoagulants, early thrombolysis, anti-platelet aggregation. The treatment group, 48 cases of Tongfu Huazhuo Fang (rhubarb 6 ~ 10g, iris 20g, turmeric 15g, bile Southern Star, Salvia 15g, earthworm 15g, peach, Tianma 12g, Astragalus, melon wilt the 30g, Scorpio Powder blunt 1g, leech powder Chong 1g, notoginseng powder blunt 3g), 1 / d, decoction 200m L, morning and evening oral; Western medicine treatment with the control group. Continuous treatment 4d for a course of treatment. Clinical symptoms, FMI score, NIHSS score, Ashworth score and adverse reactions were observed. Continuous treatment of 6 courses to determine the efficacy. [Results] The treatment group cured 12 cases, markedly effective in 23 cases, effective in 13 cases, 2 cases, the total effective rate was 95.83%. The control group recovered in 2 cases, markedly effective in 4 cases, effective in 10 cases, ineffective in 32 cases, the total effective rate was 33.33%. The treatment group than the control group (P <0.01). The index score improved in both groups (P <0.01), and the treatment group improved better than the control group (P <0.05, P <0.01). [Conclusion] Tongfu Huazhuo Decoction combined with western medicine is effective in treating ischemic cerebral apoplexy without serious adverse reactions and is worth promoting.